ANP32B and breast cancer: Here, we used Anp32b-knockout mice, multiple breast cancer cell lines and clinical patient samples to uncover the potential role for ANP32B in cell proliferation of both mouse embryo fibroblasts (MEFs) and breast cancer cells, and find that loss of ANP32B by knockout or RNAi silencing reduced rates of cell proliferation.